Trucco, Emilce <br/><br/>
Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.  [electronic resource] 

 -  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology  Feb 2016 
 - 232-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-2092 
<br/><br/><label>Standard No.: </label>10.1093/europace/euv054  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Area Under Curve<br/>Biomarkers--blood<br/>Cardiac Resynchronization Therapy--adverse effects<br/>Cause of Death<br/>Disease-Free Survival<br/>Female<br/>Heart Failure--blood<br/>Heart Transplantation<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Matrix Metalloproteinase 2--blood<br/>Middle Aged<br/>Multivariate Analysis<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Prospective Studies<br/>ROC Curve<br/>Risk Factors<br/>Time Factors<br/>Tissue Inhibitor of Metalloproteinase-1--blood<br/>Treatment Outcome<br/>Ventricular Function, Left<br/>Ventricular Remodeling